Clarivate has acquired Patient Connect, a provider of patient engagement solutions that enable the measurement of clinical and commercial outcomes and inform the advancement of healthcare.
Patient Connect patient engagement solutions improve patient outcomes by delivering clinical messaging to physicians and pharmacists at the point of patient contact. Clinical messaging is delivered in physician and pharmacist workflows, to help guide patients to better understand their treatment and disease and empower them to make informed healthcare decisions. Patient Connect has a global reach of 834,000 physicians, 600,000 pharmacists and 1,000,000,000 patients, by point of contact.
From drug discovery, clinical development and portfolio strategy through commercial planning, market access and customer engagement, Clarivate offers a wide variety of solutions providing end-to-end research intelligence to life science organizations. Clarivate real world data (RWD) products paired with Patient Connect insights will provide life science companies with global patient journey information. The acquisition addresses the increasing need for global personalized data that helps life science companies understand patient populations, supports compliant patient journey analyses and brings life-saving treatments to market.
“By combining patient journey data, therapeutic area expertise, artificial intelligence and analytics in ways that unlock hidden insights, enable informed decision-making and accelerate innovation, Clarivate empowers life science organizations to make more confident decisions along the entire drug lifecycle. The combination of Patient Connect global patient-level data with the Clarivate customer engagement suite of life science intelligence solutions will fill a critical need for RWD coverage in Europe, the United States, Asia-Pacific and Latin America.”
President, Science Group, Clarivate
Clarivate has acquired Patient Connect, furthering our goal to provide end-to-end solutions for life sciences companies along the entire drug development lifecycle. From drug discovery, clinical development and portfolio strategy through commercial planning, market access and customer engagement, Clarivate offers a wide variety of solutions providing end-to-end research intelligence to life sciences organizations.
The acquisition of Patient Connect uniquely positions Clarivate to provide life science companies global insights into mapping the patient journey and fills a critical need to expand Clarivate Real World Data coverage to include Patient Connect’s European data insights.
Together, Clarivate and Patient Connect have the power to provide:
There is no change to any product or service you currently receive from either company. Our goal will be to identify ways to enhance our current products and services, as well as introduce new services that will improve your daily operations.
Patient Connect is a patient-centric company working to help life science companies gain and retain patients by better understanding the patients they serve. Patient Connect has developed a market leading points of care digital messaging network. Patient Connect supports patients at the point of care (POC) and point of dispensing (POD) by delivering clinical messaging that drives patient acquisition and retention and, therefore, improves patient outcomes. Clinical messaging is delivered directly into physician and pharmacist workflows to help guide patients to better understand their treatment and disease, empowering patients to make informed healthcare decisions.
Patient Connect’s pioneering team of clinicians and analysts utilize advanced analytics to deliver valuable insights and a deeper understanding of patient data. Patient Connect’s clinical network has strong coverage across Europe, and expansion opportunities in the United States, Asia-Pacific and Latin America.
The acquisition is very positive for our customers. With the addition of Patient Connect to the Clarivate family, we can continue to create exceptional value for our customers through new offerings focused on integrating patient journey data and insights found in Clarivate Customer Engagement solutions with Patient Connect’s data and digital messaging solutions further enhancing our global offerings.
Our priority is, and will remain, to ensure that we are providing the best tools, analysis and innovation. This acquisition will enable us to take that commitment to the next level and be an even more valuable resource for our customers.